Clover Health Investments Cash Flow Statement
NASDAQ: CLOVHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Clover Health Investments free cash flow
In fiscal 2025, Clover Health Investments generated -$66.9 million of operating cash flow and spent $2.0 million on capital expenditures. That left free cash flow of -$69.0 million, a free-cash-flow margin of -3.6% of revenue. Free cash flow was down 307.2% from the prior year's $33.3 million.
Clover Health Investments returned $18.3 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
Clover Health Investments cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -85.55M | -43.01M | -213.36M | -339.57M | -587.76M | -136.39M | -363.74M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | -1.84M | -2.52M | -4.01M | -1.50M | 200.00K | -195.00K | -2.86M |
| Stock-Based Compensation | 103.66M | 114.33M | 140.93M | 164.31M | 163.72M | 7.08M | 3.30M |
| Change in Working Capital | -47.60M | 12.86M | 23.14M | -23.14M | -8.29M | 3.86M | -8.68M |
| Operating Cash Flow | -66.93M | 34.84M | -144.66M | -203.93M | -282.33M | -118.50M | -159.88M |
| Capital Expenditures | -2.04M | -1.56M | -584.00K | -4.47M | -723.00K | -693.00K | -23.00K |
| Investing Cash Flow | 4.08M | 565.00K | 140.01M | 95.13M | -435.45M | 137.40M | -181.91M |
| Share Repurchases | -18.30M | -1.77M | 0 | 0 | -147.00K | 0 | 0 |
| Financing Cash Flow | -53.38M | -17.36M | -5.07M | -4.96M | 925.39M | 5.84M | 333.98M |
| Net Change in Cash | -116.24M | 18.05M | -9.72M | -113.75M | 207.62M | 24.75M | -7.80M |
| Free Cash Flow | -68.98M | 33.29M | -145.25M | -208.39M | -283.05M | -119.19M | -159.90M |
This table shows 7 annual periods of Clover Health Investments's cash flow statement, from FY 2025 back to FY 2019, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CLOV's reporting calendar. What is a cash flow statement?